Skip to main content
OpenTrials

Clinical trial condition

Epidermal Growth Factor Receptor Mutations

Explore clinical trials studying Epidermal Growth Factor Receptor Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Epidermal Growth Factor Receptor Mutations trial results

Completed

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

NCT02113813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Site US10010 Washington D.C., District of Columbia, United States
  • Site US10006 Baltimore, Maryland, United States
  • Site US10012 Boston, Massachusetts, United States
  • Site US10001 Boston, Massachusetts, United States
View Trial Details

Related conditions